DeSmogBlog | Clearing the PR Pollution that Clouds Climate Science
Latest Content

Lawrence Solomon: No, you don't have it right at all - 8 days ago
Lawrence Solomon.jpg In her on-air dismemberment of the disingenuous National Post columnist Lawrence Solomon last week, Anna Maria Tremonti, host of the CBC radio show, The Current, asked Solomon... Topics: Anna Maria Tremonti, Canada, Desmogblog, Lawtrence Solomon, national post, Richard Littlemore, The Current

friends of science.jpg Deep Climate , the foremost expert in all details of the Friends of Science (FOS), has a dandy post speculating on who has been financing the recent FOS radio advertising...
Topics: calgary foundation, Friends of Science, Frontier Centre for Public Policy, Morten Paulsen, Richard Littlemore
Topics: calgary foundation, Friends of Science, Frontier Centre for Public Policy, Morten Paulsen, Richard Littlemore

morano.jpg Former Republican strategist Marc Morano is having as much fun with the stolen emails from the Climate Research Unit that he did with the Swift Boat Veteran's for Truth attack he led...
Topics: Climate Depot, Climate Gate, climate research center, climate research centre, east anglia university, stolen emails
Topics: Climate Depot, Climate Gate, climate research center, climate research centre, east anglia university, stolen emails

E-Mails Reveal Scientists' Contempt for Skeptics - 10 days ago
Hackers broke into the electronic files of one of the world's foremost climate research centers this week and posted an array of e-mails in which prominent scientists engaged in a blunt discussion of global warming research and disparaged... Topics: Competitive Enterprise Institute, Myron Ebell, Pat Michaels, Skeptic Generated News, US

Big Pharma Lobbyists Script Speeches In U.S. Congress, Industry Fights Against Generic Drugs - 10 days ago
pharma_pills.jpg While our focus here at DeSmogBlog is to expose the public relations and lobbying antics that hinder effective responses to climate change, we are always on the lookout for other... Topics: Genentech, lobbying, pharmaceutical industry, The New York Times













